Cerebellar Atrophy Reported in Dilantin Patients
The U.S. Food and Drug Administration (FDA) has approved labeling changes stating that cerebellar atrophy has been reported in patients taking phenytoin. This nervous system adverse reaction appears to occur more frequently when drug levels are elevated or when it is used long-term. Phenytoin is sold by Pfizer under the brand name … [Read more...]
Dilantin Linked to Stevens-Johnson Syndrome, a Dangerous Skin Condition
Dilantin, the anti-epileptic drug that has been in use for decades is one of many drugs associated with the related skin conditions Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Though these conditions are rare, when they do occur they put the patient at risk for permanent skin and organ damage and … [Read more...]